Welcome to the 
Delaware Society for Clinical Oncology

Evidence-based Management of Metastatic Colorectal Cancer in the Community

  • 12 Jun 2014
  • 6:30 PM
  • MSD Building and Conference Center (900 Prides Crossing, Newark, DE 19713)

This is a member only event.  

Jeffrey A. Meyerhardt, MD, MPH Associate Professor of Medicine, Dana-Farber Cancer Institute, Boston, MA  and Cathy Eng, MD, FACP Associate Professor, Associate Medical Director, Colorectal Center, Director of Network Clinical Research, GI Medical Oncology, Co-Chair SWOG Rectal Subcommittee, NCTN Institutional Grant, Lead Contact PI, The University of Texas M.D. Anderson Cancer Center will present “Evidence-based Management of Metastatic Colorectal Cancer.” 



At the conclusion of this activity, participants will be able to:


Apply emerging evidence supporting the role of prognostic and predictive markers for personalized treatment planning in mCRC


Incorporate updated clinical guidelines and newly approved agents into mCRC treatment planning


Integrate evidence-based data for patients with mCRC beyond progression


Assess emerging data from late-state clinical studies and identify relevant clinical trial opportunities for patients with mCRC


Please RSVP by Friday, June 6, 2014 to Megan Hayes by phone at 302-224-5181 or by email at megan.hayes@medsocdel.org.


Delaware Society for Clinical Oncology
c/o Megan Hayes
Medical Society of Delaware
PO Box 8155, Newark, Delaware 19714
Tel: 302-224-5181, Fax: 302-366-1354, Email: Megan.Hayes@medsocdel.org

This website brought to you by:


Terms and Conditions of Use

 Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds

Powered by Wild Apricot Membership Software